What is known about idebenone excretion into breast milk and the potential risk to a breastfed child?

Animal data show idebenone excretion into milk, and risk to a breastfed child cannot be excluded; whether to discontinue breastfeeding or discontinue or abstain from Raxone therapy must be decided by weighing breastfeeding benefits for the child against treatment benefits for the woman.